Global Healthcare Innovations Alliance



GHIA_logo_final.jpg

The Global Healthcare Innovations Alliance is a collaborative network of healthcare systems, academic institutions and corporate partners from around the world.

The Alliance creates opportunities that benefit patients everywhere through scalable technology development and commercialization. The value in partnering with The Alliance lies in the unique 360-degree perspective on patient care and innovation, established connections to resources throughout the healthcare and industry community, and deep and wide-ranging commercialization capabilities and expertise. 

Each partner brings unique capabilities, contributing to a multilateral network. In addition to innovation management and commercialization, The Alliance aims to identify intersections that can combine efforts in research, clinical investigation and technology development. 

Alliance Partners include:



MedStar Health:


The founding member of the Innovation Alliance, MedStar Heath, is the largest health care provider in the Maryland and Washington, D.C., region. MedStar’s 30,000 associates, 6,000 affiliated physicians, 10 hospitals, ambulatory care and urgent care centers, MedStar Institute for Innovation (MI2), and the MedStar Health Research Institute are recognized regionally and nationally for excellence.  MI2 houses MedStar Inventor Services, the operational unit that works directly with MedStar associates to advance their inventions and connects back to the Cleveland Clinic Innovations team.

Since the Innovation Alliance began in January 2011, there have been over 215 invention disclosures received; prior to the Alliance MedStar had no Intellectual Property infrastructure. There are currently two CCI employees on-the-ground at MedStar and their combined efforts with the MI2 team are expected to realize revenue before the end of the year.



North Shore-LIJ:


As the U.S.’s second-largest, non-profit, secular healthcare system, North Shore-LIJ delivers world-class clinical care throughout the New York metropolitan area, pioneering research at The Feinstein Institute for Medical Research. North Shore-LIJ cares for people at every stage of life at 15 hospitals, long-term care facilities and more than 200 ambulatory care centers throughout the region. The Feinstein Institute for Medical Research is home to international scientific leaders in Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, inflammatory bowel disease, human genetics, leukemia, neuroimmunology, and medicinal chemistry.

Joining the Innovation Alliance in early 2012, North Shore-LIJ has started off with a number of high quality invention disclosures. With a team of three CCI employees on the ground, there has been a strong focus on creating a sustainable program that encourages inventor engagement.


University of Notre Dame:


Recognized as one of the most prestigious universities in the world, in recent years, Notre Dame has demonstrated its commitment to strengthening its research enterprise by increasing investments in state-of-the-art facilities and infrastructure. While Notre Dame does not have a medical school, the University has grown its funded research program significantly and now secures external funding totaling more than $100 million annually. The University has invested $80 million of internal funding through its Strategic Research Investment program to advance the scope, excellence and visibility of its research and scholarship.

With approximately 50 inventor disclosures annually, Notre Dame sees the Healthcare Innovation Alliance network as an opportunity to create a commercialization pathway for innovative technologies in the biotechnology and health science space. CCI has just placed a full-time employee on-the-ground at Notre Dame and is slated to begin an aggressive internal engagement roll-out.



ProMedica:


ProMedica is a locally owned, nonprofit healthcare organization serving northwest Ohio and southeast Michigan. ProMedica has more than 14,300 employees and nearly 1,700 physicians with more than 400 healthcare providers employed by ProMedica Physicians. Its 11 hospitals and more than 306 facilities offer comprehensive diagnostic, medical and surgical specialties in heart and vascular, oncology, orthopaedics, neurology, and women and pediatric services.

Joining the Innovation Alliance in summer 2012, ProMedica sees this collaboration as an opportunity to identify news ways to engage their physicians and employees, while offering them a pathway to turn their ideas into products and services that meet the needs of their patient and communities. CCI has placed a full-time employee at ProMedica and the start-up plan is currently underway.



The Innovation Institute:


Founded by St. Joseph Health in Orange County, CA, The Innovation Institute was established to act as a multi-institutional collaborative that encourages innovation and commercialization.

Announced in November 2012, CCI is currently beginning to develop policies and procedures for The Innovation Institute and meet with senior leadership at St. Joseph.



Marshfield Clinic:


The Marshfield Clinic system provides patient care, research and education with more than 50 locations in northern, central and western Wisconsin, making it one of the largest comprehensive medical systems in the United States. The collaboration of clinical care, research, laboratory testing, education and public health services at Marshfield Clinic differentiate it from other health care providers. By combining these services, Marshfield Clinic offers patients and providers access to innovative technology, leading to comprehensive diagnosis and treatment of illness, disease and infection.



Innovations Spotlight

Commercialization Process

See how the Innovations team maximizes the commercial impact of each new invention.

Read More

Innovations Team

Cleveland Clinic Innovations (CCI) is the commercialization arm of Cleveland Clinic

Read More